By Dean Seal
Shares of Assertio Holdings fell after the company’s chief executive stepped down for undisclosed reasons.
The stock was down 10.5% at $1.02 in recent trading. Shares traded as high as $8.01 over the past 52 weeks.
The specialty pharmaceutical company said Wednesday that Dan Peisert is departing and will be succeeded for the time being by an independent director.
No reason for the departure was given. Chairman Peter Staple thanked Peisert for his contributions to Assertio as its chief executive and chief financial officer before that.
Heather Mason, an independent director and chair of its nominating and corporate governance committee will serve as interim chief executive while the company searches for a permanent successor.
Write to Dean Seal at dean.seal@wsj.com
Read the full article here
